Zimmer to distribute Baxter's Infusor:
This article was originally published in Clinica
Zimmer has gained distribution rights to Baxter Healthcare's Infusor device, allowing the former to market the product as part of a pain management kit for orthopaedic and non-oncology surgical procedures in the US. The portable and disposable Infusor employs elastomeric technology to provide a slow, continuous administration of medication following a surgical procedure. Sales of the system are expected to commence in the first quarter of 2005.
You may also be interested in...
Dispatches from a world turned upside down include FDA expressing confidence in Chinese manufacturers – to make their GDUFA payments; projections of drug shortages for ventilator patients; and the launch of new hydroxychloroquine studies.
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.